Mayo Clinic's hometown wants to be a $6.5B biotech hub

Rochester, MN, home of the Mayo Clinic, is an otherwise unassuming Midwestern city, housing about 111,000 people on the Zumbro River. But the town's leaders have a plan to transform it into a global hub of biotech research and cutting-edge medical technology, approving a $6.5 billion plan that will remake Rochester over the next 20 years. As Fast Company reports, the plan is to leverage the Mayo Clinic--and the medical tourism it drives--and effectively build a new Rochester in its image. The city is looking to start from scratch with what it calls the Destination Medical Center, a sprawling campus with room for hospitals, labs and office buildings that would unite research institutions and biopharma companies, doubling the city's current population. More

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.